STOCK TITAN

T. Rowe Price (NTRA holder) discloses 7.8% Natera ownership in 13G/A

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

T. Rowe Price Associates, Inc. reported beneficial ownership of 10,872,702 shares of Natera Inc. common stock, representing 7.8% of the class as of 12/31/2025. It has sole voting power over 10,475,212 shares and sole dispositive power over 10,871,989 shares.

The firm states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Natera. It also disclaims being the beneficial owner of the securities, despite filing this Schedule 13G/A amendment.

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake in Natera (NTRA) does T. Rowe Price Associates report?

T. Rowe Price Associates reports beneficial ownership of 10,872,702 Natera common shares, representing 7.8% of the class as of December 31, 2025. This makes it a significant institutional holder under SEC reporting rules.

What voting and dispositive power does T. Rowe Price have over Natera (NTRA) shares?

T. Rowe Price Associates reports sole voting power over 10,475,212 shares and sole dispositive power over 10,871,989 shares of Natera common stock. It reports no shared voting or shared dispositive power over any Natera shares.

Why did T. Rowe Price file an amended Schedule 13G/A for Natera (NTRA)?

The amended Schedule 13G/A reflects updated beneficial ownership information for Natera common stock as of December 31, 2025. Crossing or holding above the 5% threshold requires disclosure and updates when holdings change materially over time.

Does T. Rowe Price intend to influence control of Natera (NTRA)?

T. Rowe Price Associates states the Natera securities were acquired and are held in the ordinary course of business and not to change or influence control of the company, nor in connection with any control-related transaction or group activity.

How does T. Rowe Price characterize its beneficial ownership of Natera (NTRA)?

T. Rowe Price Associates files as a reporting person but expressly denies beneficial ownership of the Natera securities in a certification. It explains that the filing should not be construed as an admission of beneficial ownership of the reported shares.

What type of reporting person is T. Rowe Price in this Natera (NTRA) filing?

T. Rowe Price Associates is identified as a Maryland entity and checks the category for an investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E), reflecting its role managing client assets rather than holding the shares as an operating company.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Associates, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:02/17/2026